Pieter H. Reitsma

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Molecular Modeling of Protein-Peptide Complexes Mimicking Factor Xa-Prothrombin Using AlphaFold-Multimer and Molecular Dynamics Simulations for Functional Prediction.

Molecular Modeling of Protein-Peptide Complexes Mimicking Factor Xa-Prothrombin Using AlphaFold-Multimer and Molecular Dynamics Simulations for Functional Prediction.

Journal: Journal of chemical information and modeling

Published: May 23, 2026

Pseudonaja textilis venom factor Va circumvents natural regulatory mechanisms via a unique A2 domain region.

Pseudonaja textilis venom factor Va circumvents natural regulatory mechanisms via a unique A2 domain region.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 02, 2025

Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001.

Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001.

Journal: Research and practice in thrombosis and haemostasis

Published: September 10, 2025

Modifications of the Prothrombin Active Site S4 Subpocket Confer Resistance to Dabigatran.

Modifications of the Prothrombin Active Site S4 Subpocket Confer Resistance to Dabigatran.

Journal: Thrombosis and haemostasis

Published: February 12, 2025

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.

Journal: Pharmacotherapy

Published: November 20, 2023

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 30, 2023

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists.

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists.

Journal: Journal of internal medicine

Published: September 20, 2022

ptFVa (Pseudonaja Textilis Venom-Derived Factor Va) Retains Structural Integrity Following Proteolysis by Activated Protein C.

ptFVa (Pseudonaja Textilis Venom-Derived Factor Va) Retains Structural Integrity Following Proteolysis by Activated Protein C.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 24, 2021

High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case-Cohort Study.

High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case-Cohort Study.

Journal: Thrombosis and haemostasis

Published: August 28, 2020

Evolutionary Adaptations in Pseudonaja Textilis Venom Factor X Induce Zymogen Activity and Resistance to the Intrinsic Tenase Complex.

Evolutionary Adaptations in Pseudonaja Textilis Venom Factor X Induce Zymogen Activity and Resistance to the Intrinsic Tenase Complex.

Journal: Thrombosis and haemostasis

Published: August 21, 2020

Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis.

Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis.

Journal: Thrombosis research

Published: July 23, 2020

Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies.

Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies.

Journal: Seminars in thrombosis and hemostasis

Published: July 21, 2020

Showing 1-12 of 139

Last Updated: 09/26/2026